Frequently Asked Questions (FAQ)

The Institute of Pharmaceutical Research & Technology (IFET M.A.E.) is the specialized public body that ensures patient access to medicines of critical therapeutic value, which are not commercially available in Greece.

IFET M.A.E. operates as the main operational arm of the State to meet vital pharmaceutical needs, supporting the National Health System and protecting Public Health.

IFET M.A.E. serves patients who need medications that:

  • are not commercially available in Greece

  • are in short supply

  • are unique, rare or irreplaceable

IFET M.A.E. manages medicines of special therapeutic value, preparations for rare diseases, unique pharmaceutical products, as well as special antidotes and treatments that cannot be replaced.

IFET M.A.E. provides a wide range of services, such as:

  • Production of unique and irreplaceable medicines

  • Medical device sterilization services

  • Management of hazardous pharmaceutical waste

  • Wholesale and retail trade of pharmaceutical products and diagnostics

  • Quality control services

Yes. IFET M.A.E. develops active research activity in the field of Pharmaceutical Research and Technology, utilizing innovative technologies and collaborating with Academic and Research Institutions.

The aim is to develop new methodologies, enhance the quality and safety of pharmaceutical products and contribute to the development of pharmaceutical science for the benefit of patients.

IFET M.A.E. implements strict quality control procedures, modern analytical methods and high standards of compliance, so that every pharmaceutical product that reaches patients is safe and effective.

IFET M.A.E. is a subsidiary of the National Medicines Organization (EOF) and operates in close collaboration with it, as well as with the Ministry of Health and other public bodies.